EcoVadis Platinum Level Achieved in 2026
We have renewed our EcoVadis assessment and achieved the Platinum level!
Press releases
June 8, 2022
François Fournier as new CEO
Javené, June 8th, 2022 –
An experienced healthcare executive and expert in HTL’s therapeutic areas, in particular dermatology and medical aesthetics, François Fournier brings more than 20 years’ experience in corporate strategy, business execution, and international leadership.
Prior to joining HTL, François Fournier, of French and American nationality, worked in many
countries and several continents in different management positions at pharmaceutical companies,
including most recently at Virbac (as president and CEO of Virbac North America based in Dallas) and previously at Smith & Nephew and Galderma.
Read more below
To see our most recent news,
follow us on LinkedIn
Read more
news from us
-
Press releases June 10, 20262026 National Biopharmaceutical Bioproduction Day
On June 4th, as part of the 3rd edition of the National Biopharmaceutical Bioproduction Day (#JNBB2026) organized by France BioLead, HTL Biotechnology was pleased to open the doors of its Javené facility to students and teachers who came to learn about careers in bioproduction.
-
Articles May 1, 2026Health & Safety Day 2026
At HTL Biotechnology, a culture of safety is deeply ingrained in our daily operations and guides all of our industrial practices. It is part of a clear goal: striving for zero accidents by placing prevention at the heart of our actions.
-
Articles April 13, 2026EcoVadis Platinum Level Achieved in 2026
We have renewed our EcoVadis assessment and achieved the Platinum level!